National Cancer Institute
Epidemiology and Genomics Research
June 2014

About Us

Funding Opportunity
Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01)
Application due dates: July 8, 2014; November 10, 2014; March 11, 2015; July 8, 2015; November 10, 2015; March 11, 2016; July 8, 2016; November 10, 2016; and March 10, 2017
Expires: March 11, 2017   


Enabling Resources for Pharmacogenomics (R24)
Application due dates: September 25, 2014; September 25, 2015; and September 25, 2016
Expires: September 26, 2016

Global "Omics" Approaches Targeting Adverse Pregnancy and Neonatal Outcomes Utilizing Existing Cohorts (R01)
Application due dates: October 7, 2014; October 7, 2015; and October 7, 2016
Expires: October 8, 2016

Genomic Resource Grants for Community Resource Projects (U41)
Application due dates: September 25, 2014; January 25, 2015; May 25, 2015; September 25, 2015; January 25, 2016; May 25, 2016; September 25, 2016; and January 25, 2017
Expires: January 26, 2017

Interventions for Health Promotion and Disease Prevention in Native American Populations (R01)

Application due dates: May 12, 2015; May 12, 2016; and May 12, 2017
Expires: August 25, 2017
Grants Policy AnnouncementsGrantsmanshipAnnouncements
Piloting Modified NIH Biosketches
Job OpportunitiesJobOpportunity
Cancer Research Training Award Fellow, Cancer Epidemiology Cohort and Consortia Coordination

Cancer Research Training Award Fellow, Genomic Epidemiology
Upcoming Seminars & WorkshopsEvents
Science of Team Science Conference
August 6-8, 2014, in Austin, TX

IEA World Congress of Epidemiology
August 17-21, 2014 in Anchorage, AK

International Society for Environmental Epidemiology
August 24-28, 2014 in Seattle, WA

International Genetic Epidemiology Society
August 28-30, 2014, in Vienna, Austria

American College of Epidemiology
September 7-9, 2014 in Silver Spring, MD
The Epidemiology and Genomics Research Program (EGRP) in the Division of Cancer Control and Population Sciences (DCCPS)funds research in human populations to understand the causes of cancer and related outcomes.

The Program fosters interdisciplinary collaborations, as well as the development and use of resources and technologies to advance cancer research and translation of this research, which serve as the basis for clinical and public health interventions.
Send Us Your IdeasSendUsYourIdeas
EGRP encourages readers to submit items of interest to Cancer Epidemiology Matters E-News.  EGRP reserves the right to decide whether or not materials are appropriate for inclusion.
Contact UsContactUs
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
9609 Medical Center Drive
4 East, MSC 9763
Bethesda, MD  20892
(240) 276-6730

For UPS, FedEx, and courier services, please use:
Rockville, MD  20850


Expanding Cancer Outcomes Research in Cohort StudiesCohorts
Cancer remains one of the leading causes of morbidity and mortality worldwide. NCI's Division of Cancer Control and Population Sciences (DCCPS), of which the Epidemiology and Genomics Research Program (EGRP) is a part, supports research that aims to reduce the risk, incidence, and deaths from cancer worldwide, and to enhance the quality of life for cancer survivors. Although numerous epidemiologic studies have investigated factors that affect cancer risk, far fewer have addressed the extent to which demographic, lifestyle, genomic, clinical, and psychosocial factors influence recurrence, survival, and other cancer outcomes. Understanding how these factors are related may help identify those at high risk for poor outcomes and inform optimal management strategies for cancer survivors.

EGRP's Clinical and Translational Epidemiology Branch (CTEB) focuses on etiologic and genomic factors that influence cancer progression, recurrence, survival, and other treatment outcomes. EGRP has a long history of supporting cancer epidemiology cohort studies. In March 2014 when NCI reissued  PAR-14-160 which supports infrastructure and methodological research for cancer epidemiology cohorts-the required number of study participants was reduced to 5,000 across cancer sites or 2,000 per site for cohorts of cancer patients and survivors.

During a November 2011 EGRP-sponsored workshop focused on utilizing data from cancer patient and survivor studies, more than 50 cancer patient and survivor cohorts  were identified that may be of interest to cancer outcomes researchers. CTEB staff continue to build this resource and welcome suggestions for additional studies to be included.

CRTA Fellowships in EGRP: Making Important Scientific ContributionsFellows
NCI's Cancer Research Training Award (CRTA) Fellowship program exists to provide individuals with high-quality training in scientific disciplines that will enhance public health efforts to prevent, diagnose, or treat cancer. Fellows in the CRTA program frequently work with scientists and public health professionals at NCI, the National Institutes of Health (NIH), and research institutions around the country. Fellowships vary in duration from the course of a summer to 3 years and are open to individuals who are pursuing or have completed undergraduate, graduate, or doctoral studies.

In the past 2 years alone, EGRP has hosted more than a dozen CRTA Fellows. These talented Fellows support EGRP's mission by researching a variety of scientific areas, contributing to scholarly publications, and providing valuable support to EGRP staff. To highlight the excellent work that our Fellows do every day, this article features projects that current Fellows have worked on and what they have learned from those experiences.

Amy Kennedy, Ph.D., M.P.H.
Amy Kennedy, Ph.D., M.P.H. joined EGRP's Cohorts and Consortia Team in March 2014. She has been working on a cohort-mapping effort that involves analyzing publications in PubMed to identify all cohorts worldwide with more than 10,000 participants. The goal of the project is to establish a public registration site that researchers can use to find studies of interest and potential collaborations across the world. Amy says she was surprised to learn just how many cohorts exist and how valuable a comprehensive list would be for improving research and promoting collaboration.
Brittany Stallworth

Brittany Stallworth has been working in EGRP's Modifiable Risk Factors Branch
since June 2013.  She has been analyzing the distribution of funding by DCCPS of research on obesity-related cancers, stratified by the ethnicity and gender of study participants. Brittany says the project opened her eyes to the breadth and variety of approaches that exist for researching a single health problem. In the fall she will start an internship with the Beaumont Health System in Detroit. 
Elizabeth Hebert
Since July 2013, Elizabeth Hebert has been working with EGRP's Methods and Technologies Branch.  As part of her Fellowship, Elizabeth reviewed published literature and DCCPS-funded grants to identify trends of microbiome analysis within cancer epidemiology. Elizabeth says her project work helped hone her ability to identify knowledge gaps and areas for improvement in large epidemiology studies.
Hayley Aja, M.P.H.
Hayley Aja, M.P.H., began working with the Modifiable Risk Factors Branch in July 2013.  Hayley has been using data from NCI's Health Information National Trends Survey (HINTS) to examine respondents' risk perception for different indoor and outdoor sources of air pollution and determine whether certain sociodemographic characteristics predict increased concern about the effects of such pollutants. She also worked with an NCI-wide group that collaborates to analyze survey data and write, test, and distribute future iterations of the survey. Hayley says these experiences have taught her a great deal about survey methodology and the benefits of collaborative work.

Michael Marrone, M.P.H.
Michael Marrone, M.P.H. joined the Clinical and Translational Epidemiology Branch in September 2013.  Michael has been investigating the validity and utility of next-generation sequencing tests that are used to inform individualized cancer treatment strategies in clinical settings. Michael says his work on this project has taught him about new paradigms in precision oncology (the shift to studying cancer by molecular markers rather than tumor type) and to what degree multiplex tumor sequencing results can depend on the particular sequencing platforms used. After his Fellowship, Michael will be pursuing his Ph.D. in cancer epidemiology  at Johns Hopkins University.

Sharna Tingle, M.P.H. has been working with staff
Sharna Tingle, M.P.H.
in EGRP's Host Susceptibility Factors Branch since September 2012. During her Fellowship, Sharna had the opportunity to work on a public health genomics project that examined the translational milestones affecting the clinical utility and recommendation of genomic tests for cancer. Sharna says she learned how guidelines can vary across recommending organizations and that recommendation categories can change as new evidence becomes available.

At the conclusion of the Fellowship, many EGRP Fellows find positions at NIH or other government agencies, either as contractors or federal employees. Some have taken positions as researchers for private institutions such as universities or cancer centers, while others have pursued advanced degrees in science, medicine, and law.

EGRP is recruiting for new CRTA Fellows. Anyone interested in becoming a Fellow in EGRP should visit our job opportunities webpage.
This email was sent to by 

Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute | 9609 Medical Center Drive | 4 East, MSC 9763 | Bethesda | MD 20892

Contact Us | Privacy Policy | Accessibility | FOIA

U.S. Department of Health and Human Services
National Institutes of Health | National Cancer Institute |